Get notified of page updates
Glossary on
off
Clinicaltrials.gov identifier:
NCT04674306
Treatment study for people with stage 2 or 3 triple-negative breast cancer at high risk for recurrence
Testing a Vaccine for Treating or Preventing Triple-Negative Breast Cancer
About the Study
NOTE: This study is no longer recruiting people.
Researchers are studying the affects of this breast cancer vaccine on the immune system in the following groups:
- Treatment arms:
- people diagnosed with 2 or 3 who have completed treatment and are considered at high risk for recurrence.
- people diagnosed with 2 or 3 who have completed chemotherapy and radiation and are currently receiving Keytruda (pembrolizumab).
- Prevention arm:
- people with an in , , or , who have not been diagnosed with cancer, and who are planning to undergo a risk-reducing mastectomy.
This Study is Open To:
NOTE: This study is no longer recruiting people.
This Study is Not Open To:
NOTE: This study is no longer recruiting people.